Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy

Risks and benefits of combining aspirin

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

✍ Greg C. Flaker; Michael Gruber; Stuart J. Connolly; Steven Goldman; Sandra Chapa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Use of oral anticoagulation among stroke

Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study

✍ Qingchun Gao; Xian Fu; Jade W. Wei; Xiangyan Chen; Yining Huang; Jiguang Wang; C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

## Objectives: The objective of this study was to compare the predictive performance of bleeding risk-estimation tools in a cohort of patients with atrial fibrillation (af) undergoing anticoagulation. ## Background: Three bleeding risk-prediction schemes have been derived for and validated in pat

PRM26 The Use of Claims-Based CHA2DS2-VA

PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

✍ D.C. Malone; S.L. Charland; B.C. Agatep; V. Herrera; G.S. Hawk; B.J. Schrader; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB